World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jul. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
211 Zymeworks Inc. $976.0 M Canada Canadian Healthcare Canadian Biotechnology
212 Maravai LifeSciences Holdings, Inc. $975.5 M United States US Healthcare US Biotechnology
213 Nurix Therapeutics, Inc. $970.5 M United States US Healthcare US Biotechnology
214 Gracell Biotechnologies Inc. $968.6 M

(Jan. 1, 2024)

 China Chinese Healthcare Chinese Biotechnology
215 Praxis Precision Medicines, Inc. $962.6 M United States US Healthcare US Biotechnology
216 Akebia Therapeutics, Inc. $950.7 M United States US Healthcare US Biotechnology
217 Ocumension Therapeutics $938.4 M China Chinese Healthcare Chinese Biotechnology
218 HitGen, Inc. $927.8 M China Chinese Healthcare Chinese Biotechnology
219 Poseida Therapeutics, Inc. $925.9 M

(Jan. 1, 2025)

 United States US Healthcare US Biotechnology
220 Anavex Life Sciences Corp. $921.2 M United States US Healthcare US Biotechnology
221 ORIC Pharmaceuticals, Inc. $920.4 M United States US Healthcare US Biotechnology
222 Provention Bio, Inc. $912.0 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
223 Geron Corporation $910.8 M United States US Healthcare US Biotechnology
224 Albireo Pharma, Inc. $910.7 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
225 CStone Pharmaceuticals $897.2 M China Chinese Healthcare Chinese Biotechnology
226 Arcus Biosciences, Inc. $896.8 M United States US Healthcare US Biotechnology
227 Ambrx Biopharma, Inc. $878.1 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
228 CorMedix Inc. $864.9 M United States US Healthcare US Biotechnology
229 Cogent Biosciences, Inc. $863.0 M United States US Healthcare US Biotechnology
230 Jiangsu Aidea Pharmaceutical Co. Ltd $849.3 M China Chinese Healthcare Chinese Biotechnology
231 HBM Holdings Ltd $848.3 M China Chinese Healthcare Chinese Biotechnology
232 TaiMed Biologics, Inc. $838.4 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
233 Lumosa Therapeutics Co. Ltd $825.5 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
234 Mesoblast Limited $816.3 M

(July 1, 2024)

 Australia Australian Healthcare Australian Biotechnology
235 Avid Bioservices, Inc. $796.3 M

(Jan. 1, 2025)

 United States US Healthcare US Biotechnology
236 Intercept Pharmaceuticals, Inc. $794.7 M

(Nov. 1, 2023)

 United States US Healthcare US Biotechnology
237 Chempartner Pharmatech Co. Ltd $792.4 M China Chinese Healthcare Chinese Biotechnology
238 Alphamab Oncology $790.6 M China Chinese Healthcare Chinese Biotechnology
239 uniQure N.V. $789.5 M Netherlands Dutch Healthcare Dutch Biotechnology
240 Syndax Pharmaceuticals, Inc. $774.4 M United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2025

211. Zymeworks Inc.

Company Profile: Zymeworks Inc.
Market Cap (USD): $976.0 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

212. Maravai LifeSciences Holdings, Inc.

Company Profile: Maravai LifeSciences Holdings, Inc.
Market Cap (USD): $975.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

213. Nurix Therapeutics, Inc.

Company Profile: Nurix Therapeutics, Inc.
Market Cap (USD): $970.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

214. Gracell Biotechnologies Inc.

Company Profile: Gracell Biotechnologies Inc.
Market Cap (USD): $968.6 M (Jan. 1, 2024)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

215. Praxis Precision Medicines, Inc.

Company Profile: Praxis Precision Medicines, Inc.
Market Cap (USD): $962.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

216. Akebia Therapeutics, Inc.

Company Profile: Akebia Therapeutics, Inc.
Market Cap (USD): $950.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

217. Ocumension Therapeutics

Company Profile: Ocumension Therapeutics
Market Cap (USD): $938.4 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

218. HitGen, Inc.

Company Profile: HitGen, Inc.
Market Cap (USD): $927.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

219. Poseida Therapeutics, Inc.

Company Profile: Poseida Therapeutics, Inc.
Market Cap (USD): $925.9 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

220. Anavex Life Sciences Corp.

Company Profile: Anavex Life Sciences Corp.
Market Cap (USD): $921.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

221. ORIC Pharmaceuticals, Inc.

Company Profile: ORIC Pharmaceuticals, Inc.
Market Cap (USD): $920.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

222. Provention Bio, Inc.

Company Profile: Provention Bio, Inc.
Market Cap (USD): $912.0 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

223. Geron Corporation

Company Profile: Geron Corporation
Market Cap (USD): $910.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

224. Albireo Pharma, Inc.

Company Profile: Albireo Pharma, Inc.
Market Cap (USD): $910.7 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

225. CStone Pharmaceuticals

Company Profile: CStone Pharmaceuticals
Market Cap (USD): $897.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

226. Arcus Biosciences, Inc.

Company Profile: Arcus Biosciences, Inc.
Market Cap (USD): $896.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

227. Ambrx Biopharma, Inc.

Company Profile: Ambrx Biopharma, Inc.
Market Cap (USD): $878.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

228. CorMedix Inc.

Company Profile: CorMedix Inc.
Market Cap (USD): $864.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

229. Cogent Biosciences, Inc.

Company Profile: Cogent Biosciences, Inc.
Market Cap (USD): $863.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

230. Jiangsu Aidea Pharmaceutical Co. Ltd

Company Profile: Jiangsu Aidea Pharmaceutical Co. Ltd
Market Cap (USD): $849.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

231. HBM Holdings Ltd

Company Profile: HBM Holdings Ltd
Market Cap (USD): $848.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

232. TaiMed Biologics, Inc.

Company Profile: TaiMed Biologics, Inc.
Market Cap (USD): $838.4 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

233. Lumosa Therapeutics Co. Ltd

Company Profile: Lumosa Therapeutics Co. Ltd
Market Cap (USD): $825.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

234. Mesoblast Limited

Company Profile: Mesoblast Limited
Market Cap (USD): $816.3 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

235. Avid Bioservices, Inc.

Company Profile: Avid Bioservices, Inc.
Market Cap (USD): $796.3 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

236. Intercept Pharmaceuticals, Inc.

Company Profile: Intercept Pharmaceuticals, Inc.
Market Cap (USD): $794.7 M (Nov. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

237. Chempartner Pharmatech Co. Ltd

Company Profile: Chempartner Pharmatech Co. Ltd
Market Cap (USD): $792.4 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

238. Alphamab Oncology

Company Profile: Alphamab Oncology
Market Cap (USD): $790.6 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

239. uniQure N.V.

Company Profile: uniQure N.V.
Market Cap (USD): $789.5 M
Country: Netherlands
Sector: Dutch Healthcare
Industry: Dutch Biotechnology

240. Syndax Pharmaceuticals, Inc.

Company Profile: Syndax Pharmaceuticals, Inc.
Market Cap (USD): $774.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Stay in touch